Newcastle disease virus co-expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy

Rescue of nonlytic Newcastle Disease Virus (NDV) expressing IL-15 for cancer immunotherapy

(2017) Xiaojing Xu et al.   VIRUS RESEARCH

Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion

(2017) Johan M.J. Van den Bergh et al.   Cancer Immunology Research

Vector-based genetically modified vaccines: Exploiting Jenner’s legacy

(2016) Bahar Ramezanpour et al.   VACCINE

Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance

(2016) A. L. Doedens et al.   Cancer Immunology Research

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

(2015) P. R. Rhode et al.   Cancer Immunology Research

Autologous Tumor Vaccine Modified with Recombinant New Castle Disease Virus Expressing IL-7 Promotes Antitumor Immune Response

(2014) Lixiang Zhao et al.   JOURNAL OF IMMUNOLOGY

Newcastle disease virus: Current status and our understanding

(2014) Ketan Ganar et al.   VIRUS RESEARCH

IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors

(2012) N. Cieri et al.   BLOOD

IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite

(2012) Rajarshi Bhadra et al.   MICROBES AND INFECTION

Hybrid- and complex-type N-glycans are not essential for Newcastle disease virus infection and fusion of host cells

(2011) Q. Sun et al.   GLYCOBIOLOGY

The hemagglutinin–neuraminidase gene of Newcastle Disease Virus: A powerful molecular adjuvant for DNA anti-tumor vaccination

(2010) Jing Ni et al.   VACCINE

IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo

(2009) Esther Cha et al.   BREAST CANCER RESEARCH AND TREATMENT

Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma

(2009) Jennifer Altomonte et al.   MOLECULAR THERAPY